Comparison of device ‐specific adverse event profiles between Impella platforms

ConclusionsThis study suggests that for patients who require temporary MCS for more than 24  h, the Impella 5.0/LD may have a more favorable device‐specific adverse profile compared with the Impella CP.

Source: Journal of Cardiac Surgery - September 15, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Stacey Chen, Darien Paone, Lilly Spellman, Neel K. Ranganath, Julius A. Carillo, Claudia G. Gidea, Alex Reyentovich, Craig A. Thompson, Louai Razzouk, Zachary N. Kon, Nader Moazami, Deane E. Smith Tags: ORIGINAL ARTICLE Source Type: research